Chronic Non-Malignant Pain in Cancer Patients at a Supportive Care Clinic

March 27, 2023 updated by: M.D. Anderson Cancer Center
The goal of this research study is to learn how frequently cancer patients in the Supportive Care Center have chronic, non-malignant pain. Chronic, non-malignant pain is pain that is neither related to cancer nor its treatment and lasts beyond the normal tissue healing time of 3 months.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

If participant is found to be eligible and agrees to take part in this study, participant will be asked to complete 3 questionnaires about participant's pain, pain level, and what drugs participant takes to treat participant's pain. Participant will also be asked a few questions about tobacco use. These questionnaires should take about 20 minutes to complete.

Researchers will also collect information from participant's medical record such as participant's date of birth, sex, race, marital status, economic background, and medical history.

Length of Study:

Participation on this study will be over after participant has completed the last questionnaire.

This is an investigational study.

Up to 200 participants will be enrolled in this study. All will take part at MD Anderson.

Study Type

Observational

Enrollment (Actual)

201

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Texas
      • Houston, Texas, United States, 77030
        • University of Texas MD Anderson Cancer Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Participants undergoing consultation at the Supportive Care Clinic at MD Anderson Cancer Center.

Description

Inclusion Criteria:

  1. Diagnosis of cancer with or without active disease
  2. Consultation visit at an outpatient supportive care clinic
  3. Age 18 or greater
  4. Report of having pain within the last 3 months

Exclusion Criteria:

1) Memorial Delirium Assessment Scale >13

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Chronic Non-Malignant Pain - Cancer Patients
Chronic non-malignant pain among cancer patients undergoing a consultation at the outpatient Supportive Care Clinic at MD Anderson Cancer Center.
Behavioral: Questionnaires
Participants complete three questionnaires at consultation visit.
Other Names:
  • Surveys

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Frequency of Chronic Non-Malignant Pain Among Cancer Patients
Time Frame: 1 day
Frequency assessed by Edmonton Symptom Assessment Scale (ESAS-FS)
1 day
Frequency of Chronic Non-Malignant Pain Among Cancer Patients
Time Frame: 1 day
Frequency assessed by Brief Pain Inventory.
1 day
Frequency of Chronic Non-Malignant Pain Among Cancer Patients
Time Frame: 1 day
Frequency assessed by the Charlson Comorbidity Index.
1 day
Frequency of Chronic Non-Malignant Pain Among Cancer Patients
Time Frame: 1 days
Frequency assessed by Pain Characteristic Survey.
1 days
Frequency of Chronic Non-Malignant Pain Among Cancer Patients
Time Frame: 1 day
Frequency assessed by Karnofsky Performance Scale.
1 day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

M.D. Anderson Cancer Center

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 31, 2018

Primary Completion (Actual)

March 23, 2023

Study Completion (Actual)

March 23, 2023

Study Registration Dates

First Submitted

February 2, 2017

First Submitted That Met QC Criteria

February 2, 2017

First Posted (Estimate)

February 6, 2017

Study Record Updates

Last Update Posted (Actual)

March 28, 2023

Last Update Submitted That Met QC Criteria

March 27, 2023

Last Verified

March 1, 2023

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2016-0901
  • NCI-2018-01268 (Registry Identifier: NCI CTRP)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Malignant Neoplasms of Independent (Primary) Multiple Sites

Clinical Trials on Questionnaires

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Sweden

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe